Assertio Therapeutics
Presence
Assertio Therapeutics is one of the...
Assertio Therapeutics is a company listed under the stock ticker DEPO (US).
Executives
View the org chart displaying its 16 main executives
Most searched biographies at Assertio Therapeutics
- Brendan O'Grady, Chief Executive Officer and Director
- James Tyree, Independent Director
- Heather Mason, Director
Popular executive movements at Assertio Therapeutics
- Brendan O'Grady has joined the company as Chief Executive Officer and Director (posted on May 30 2024).
- Sigurd Kirk has joined the company as Director (posted on April 5 2024).
- Daniel Peisert, Chief Executive Officer and Director, has left the company (posted on January 4 2024).
Click here to view some more movements at Assertio Therapeutics
Create your alert
to follow the executive moves at Assertio Therapeutics.
Pharmaceuticals
Assertio Therapeutics has 1,857 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Sanofi (France).
Popular M&A news in Pharmaceuticals
- LakeShore Biopharma will change its company name to LakeShore Biopharma on May 24, 2024. (posted on May 25 2024).
- MedMen has filed for bankruptcy protection (posted on April 28 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Assertio Therapeutics
- Assertio Holdings, Inc. to Report First Quarter 2024 Financial Results on May 6, 2024
- Assertio Reports First Quarter 2024 Financial Results
- Sig Kirk Joins Assertio Board of Directors
- Assertio to Present at LD Micro Invitational Conference in New York City
- Assertio Reports Fourth Quarter and Full Year 2023 Financial Results
- Assertio Holdings, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
- Assertio Holdings, Inc. - Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Assertio Holdings, Inc. - Assertio Holdings, Inc. Announces Leadership Transition
- Assertio Holdings, Inc. - Assertio Reports Third Quarter 2023 Financial Results
- Assertio Holdings, Inc. - Assertio Holdings, Inc. Appoints Sravan Emany to Its Board of Directors
- View more press releases Close
Social media about Assertio Therapeutics
- Assertio Therapeutics on Wikipedia, Google News & Yahoo Finance
- Assertio Therapeutics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Sigurd Kirk 
Call Assertio Therapeutics at +1 510...
